eNauka - pregled
Pregled prema Autor Reck, M
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2022 | Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100 | Reck, M; ...; Andric, Zoran G   ; ...; (broj, koautora 19) | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2007 | Erlotinib in patients with advanced non-small-cell lung cancer (NSCLC): interim results from the European subpopulation of the open-label TRUST study | Smit, E; Reck, M; Krzakowski, M; Gridelli, C; Curescu, S; Berzinec, Peter; Barata, F; McDermott, R; Jovanovic, D; Magyarlo, P | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2024 | Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo) | Kao, SCH; Reck, M; Liu, SV; Dziadziuszko, R; Hochmair, MJ; Huemer, F; Gilberto, de Castro J; Bernabe, Caro R; Kim, SH; Kowalski, DM;
Andric, Zoran G
; Oancea, M; Kaul, M; Li, H; Danner, B; Lee, MC; Nabet, BY; Sugawara, S; | Konferencijski rad | Mp. category will be shown later |